Trials / Completed
CompletedNCT02330172
Sugammadex Provide Better Surgical Condition Compared With Neostigmine in Laryngeal Microsurgery.
Comparison Sugammadex With Neostigmine in Laryngeal Microsurgery.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to make a comparison of surgical condition and recovery time between rocuronium 0.45 mg/kg and neostigmine group and rocuronium 0.9 mg/kg and sugammadex group.
Detailed description
This study aims to make a comparison of surgical condition and recovery time between moderate neuromuscular bloackade with reversal using neostigmine group and deep neuromuscular bloackade with reversal using sugammadex group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Injection of neostigmine or sugammadex | At anesthetic induction, rocuronium 0.45 to rocuronium 0.45 - neostigmine group or rocuronium 0.9 mg/kg to rocuronium 0.9 - sugammadex group will be injected for muscle relaxation. During surgical procedure, we will monitor train of four (TOF) using nerve stimulator. After operation, neostigmine 50 mcg/kg or sugammadex 4 mg/kgl be injected. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-01-01
- Last updated
- 2017-04-17
- Results posted
- 2017-04-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02330172. Inclusion in this directory is not an endorsement.